E Fund Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Buy |
29,683
+8,811
| +42% | +$160K | 0.03% | 218 |
|
|
2025
Q1 | $414K | Sell |
20,872
-15,597
| -43% | -$309K | 0.02% | 246 |
|
|
2024
Q4 | $625K | Buy |
36,469
+11,351
| +45% | +$195K | 0.03% | 194 |
|
|
2024
Q3 | $502K | Buy |
25,118
+8,120
| +48% | +$162K | 0.03% | 195 |
|
|
2024
Q2 | $190K | Sell |
16,998
-15,243
| -47% | -$170K | 0.01% | 295 |
|
|
2024
Q1 | $213K | Buy |
32,241
+3,181
| +11% | +$21K | 0.01% | 333 |
|
|
2023
Q4 | $131K | Sell |
29,060
-3,069
| -10% | -$13.9K | 0.01% | 297 |
|
|
2023
Q3 | $115K | Sell |
32,129
-6,484
| -17% | -$23.2K | 0.01% | 277 |
|
|
2023
Q2 | $142K | Sell |
38,613
-17,090
| -31% | -$62.8K | 0.01% | 290 |
|
|
2023
Q1 | $184K | Buy |
55,703
+14,327
| +35% | +$47.3K | 0.01% | 309 |
|
|
2022
Q4 | $161K | Buy |
41,376
+1,518
| +4% | +$5.91K | 0.01% | 311 |
|
|
2022
Q3 | $97K | Buy |
+39,858
| New | +$97K | 0.01% | 328 |
|